CRIS Current Research Information System

NANNI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.511
AS - Asia 2.899
EU - Europa 2.896
AF - Africa 186
SA - Sud America 173
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.670
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.483
SG - Singapore 875
CN - Cina 836
GB - Regno Unito 835
VN - Vietnam 725
SE - Svezia 443
DE - Germania 398
IT - Italia 297
UA - Ucraina 219
HK - Hong Kong 191
RU - Federazione Russa 176
IN - India 142
FR - Francia 140
BR - Brasile 129
IE - Irlanda 108
EE - Estonia 75
ZA - Sudafrica 70
CH - Svizzera 55
TG - Togo 42
FI - Finlandia 41
JP - Giappone 41
AR - Argentina 27
NL - Olanda 26
CI - Costa d'Avorio 25
SC - Seychelles 23
KR - Corea 21
JO - Giordania 20
BG - Bulgaria 19
BE - Belgio 18
CA - Canada 18
NG - Nigeria 15
IR - Iran 12
PL - Polonia 11
GR - Grecia 10
ID - Indonesia 8
MX - Messico 7
AT - Austria 6
EC - Ecuador 6
BD - Bangladesh 5
CL - Cile 5
ES - Italia 5
LB - Libano 5
CZ - Repubblica Ceca 4
MA - Marocco 4
RO - Romania 4
BJ - Benin 3
CO - Colombia 3
IQ - Iraq 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
MU - Mauritius 2
PH - Filippine 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
CM - Camerun 1
DZ - Algeria 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
ME - Montenegro 1
MY - Malesia 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
TR - Turchia 1
TV - Tuvalu 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 10.670
Salva come PNG Salva come JPEG
Città #
Southend 749
Singapore 558
Fairfield 552
Ashburn 449
Chandler 344
Houston 291
Wilmington 257
Seattle 242
Woodbridge 240
Cambridge 202
Hong Kong 191
Dong Ket 175
Princeton 169
Ann Arbor 166
Jacksonville 149
Santa Clara 140
Boardman 119
Beijing 109
Dublin 108
Nanjing 80
Padova 78
Westminster 78
Bologna 53
Los Angeles 52
Bern 50
Jinan 48
Shenyang 47
Berlin 46
Hefei 43
Lomé 42
Dallas 41
Helsinki 40
Tokyo 40
Saint Petersburg 39
Changsha 38
Mülheim 34
Hebei 32
Nanchang 32
New York 32
San Diego 31
Ho Chi Minh City 29
Milan 29
Bremen 26
Buffalo 26
Hanoi 26
Abidjan 25
Guangzhou 24
Dearborn 21
Redondo Beach 21
Amman 20
Seoul 20
Turin 20
Haikou 19
Mahé 19
Sofia 19
Tianjin 19
Jiaxing 18
Brussels 16
São Paulo 16
Abeokuta 14
Falkenstein 14
Medford 14
Des Moines 13
Zhengzhou 13
Frankfurt am Main 12
Hangzhou 12
Redwood City 12
Falls Church 11
Kunming 11
Yubileyny 11
Florence 10
Shanghai 10
Warsaw 10
Ningbo 9
Olalla 9
Taizhou 9
Wuhan 9
Brooklyn 8
Düsseldorf 8
Norwalk 8
Paris 8
Taiyuan 8
Bühl 7
Lanzhou 7
Lauterbourg 7
Mountain View 7
Ottawa 7
The Dalles 7
Biên Hòa 6
Buenos Aires 6
Chengdu 6
Kuban 6
London 6
Munich 6
Verona 6
Costa Mesa 5
Haiphong 5
Monmouth Junction 5
Ninh Bình 5
Redmond 5
Totale 6.951
Salva come PNG Salva come JPEG
Nome #
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma. 236
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 226
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 207
A novel model of CCl4-induced cirrosi with ascites in the mouse. 207
Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT? 199
68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. 197
A review discussing fluciclovine (18F) PET/CT imaging in the detection of recurrent prostate cancer 195
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. 193
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. 190
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. 187
18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin 182
18F-FACBC COMPARED WITH 11C-CHOLINE PET/CT IN PATIENTS WITH BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY: A PROSPECTIVE STUDY IN 79 PATIENTS 182
Contrast enhanced MRI and (18)F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease 173
Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. 168
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. 168
18F-FACBC PET/CT in comparison to 11c-choline for the detection of prostate cancer relapse after radical prostatectomy: A perspective study in 50 patients 166
The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients. 165
18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse A Comparison to 11C-Choline PET/CT 164
68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results. 164
11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy 162
Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results 162
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas 160
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 155
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. 154
Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target. 153
Evaluation of unusual neuroendocrine tumours by means of (68)Ga-DOTA-NOC PET. 153
The Possible Role of PET Imaging Toward Individualized Management of Bone and Soft Tissue Malignancies. 151
TOMOGRAFIA AD EMISSIONE DI POSITRONI CON 11-C-COLINA INTEGRATO A UN SISTEMA TC (11-C-CHOLINE-PET/TC) E RISONANZA MAGNETICA DI SPETTROSCOPIA DEL PROTONE (1-H-MRSI) NELLA DIAGNOSI DI NEOPLASIA PROSTATICA: STUDIO COMPARATIVO 149
Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET. 148
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Review 147
(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. 145
Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma. 144
Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I. 143
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. 143
Efficacy of PHA-848125, a cyclin-dependent kinase inhibitor, on the K-Ras(G12D)LA2 lung adenocarcinoma transgenic mouse model: evaluation by multimodality imaging. 141
FUNCTIONAL AND HISTOPATHOLOGICAL IMPROVEMENT OF THE POST-INFARCTED RAT HEART UPON MYOBLAST CELL GRAFTING AND RELAXIN THERAPY. 138
18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone. 138
Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET. 138
18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR. 137
Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion. 136
The role of (18)F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective study. 134
Role of (11)C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy 133
Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study. 131
Small animal PET for the evaluation of an animal model of genital infection 130
FDG-PET and PET/CT for evaluating soft tissue sarcomas 129
Molecular Imaging of Neuroblastoma Progression in TH-MYCN Transgenic Mice 127
First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection. 127
Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? 124
Detection of liver lesions during 11C-Choline PET/CT in relapsing prostate cancer patients 123
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation 122
Ga-68-DOTA-peptides versus F-18-DOPA PET for the assessment of NET patients 119
Imaging with (11)Carbon labelled PET tracers. 119
I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report. 119
Small animal PET in oncology: the road from bench to bedside. 118
Contouring carcinomas by FDG-PET: is the role of tumor biology underestimated? In regard to MacManus et al. (Int J Radiat Oncol Biol Phys 2008;71:2-4). 117
Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour? 117
Positron-emission tomography in gynaecologic malignancies. 116
Present and future of PET and PET/CT in gynaecologic malignancies. 114
Feasibility of carbidopa premedication in pediatric patients: a pilot study. 114
PET Tracers Beyond FDG in Prostate Cancer. 113
PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancer. 108
Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs. 107
PET/CT in the management and prognosis of pancreatic exocrine tumors. 104
Dall'imaging anatomico al metabolico (neoplasie del polmone) 102
PET/TC e TC nella stadiazione pre- e post-chemioterapia neoadiuvante in pazienti con carcinoma ovarico ad alto grado di malignità. 101
The Value of 18F-FDG PET/CT after Autologous Stem Cell Transplantation (ASCT) in Patients Affected by Multiple Myeloma (MM): Experience With 77 Patients 101
Positron emission tomography for the evaluation of soft-tissue sarcomas and bone sarcomas. 101
Preclinical studies with small animal PET 99
Follow-up delle neoplasie polmonari 98
Linfomi. Imaging metabolico 97
Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy. 97
Follow-up / Corso monotematico 95
Nutraceuticals & gut: phytosterol & ulcerative colits. 94
Dall'imaging anatomico al metabolico/ Corso monotematico 93
PET-CT: Rare Findings and Diseases 89
Linfomi: imaging metabolico/ Corso monotematico 79
The clinical use of PET with (11)C-acetate. 78
PET/CT in Oncology 78
Totale 10.833
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.257
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021804 0 0 0 0 0 60 18 83 119 59 78 387
2021/20221.719 429 58 103 144 127 83 29 95 47 86 295 223
2022/20231.539 156 210 93 241 95 116 47 74 240 66 119 82
2023/2024338 38 73 16 31 31 59 20 11 19 18 9 13
2024/20251.337 38 280 136 96 265 74 102 23 12 67 31 213
2025/20261.432 176 243 286 176 371 180 0 0 0 0 0 0
Totale 10.833